Omniome’s High Accuracy Short-Read Sequencing Platform Expected to Significantly Expand PacBio’s Market Opportunity. Acquisition Expected to Accelerate the Adoption of SMRT Sequencing, PacBio’s Leading Long-Read Sequencing Platform. PacBio Also Closes…
MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: Wells…
MENLO PARK, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conference: UBS…
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2021. Record second quarter…
Technology Will Enable Continued End-to-End Automated Workflow Development MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading…
MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced…
Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper clinical insights and…
Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing platform, with PacBio’s market leading,…
MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results…
HiFi Sequencing Will Be Used on a Cohort of Rare Disease Cases With the Aim to Identify Numerous Variants, Both Small and Structural, That Are Not Readily Detectable by Short-Read…
MENLO PARK, Calif., June 11, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced…
Industry Veteran Will Lead PacBio’s Commercial Footprint Across the Region MENLO PARK, Calif., June 08, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of…
MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes,…
Kathleen Lynch Has Joined as Head of Global Government Affairs and Communications and Michele Farmer Has Joined as Chief Accounting Officer MENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) —…
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: BofA…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.